erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Goodman LJ et al. Effects of erythromycin and ciprofloxacin on chronic fecal excretion of Campylobacter species in marmosets. 1986 Antimicrob. Agents Chemother. pmid:2940963
Hoban DJ et al. Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides. 2001 Antimicrob. Agents Chemother. pmid:11408241
Clewell DB and Franke AE Characterization of a plasmid determining resistance to erythromycin, lincomycin, and vernamycin Balpha in a strain Streptococcus pyogenes. 1974 Antimicrob. Agents Chemother. pmid:4618462
Hand WL and King-Thompson NL Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity. 1986 Antimicrob. Agents Chemother. pmid:3790206
Lee H et al. Isolation of antibiotic hypersusceptibility mutants of Acinetobacter spp. by selection for DNA release. 2003 Antimicrob. Agents Chemother. pmid:12654657
Conejo Mdel C et al. Activities of ABT-773 against Listeria monocytogenes and coryneform bacteria of clinical interest. 2003 Antimicrob. Agents Chemother. pmid:12654678
Ng LK et al. Can Etest be used to determine Vibrio cholerae susceptibility to erythromycin? 2003 Antimicrob. Agents Chemother. pmid:12654699
Sutcliffe J et al. Detection of erythromycin-resistant determinants by PCR. 1996 Antimicrob. Agents Chemother. pmid:8913465
Retsema J et al. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. 1987 Antimicrob. Agents Chemother. pmid:2449865
Donowitz GR and Earnhardt KI Azithromycin inhibition of intracellular Legionella micdadei. 1993 Antimicrob. Agents Chemother. pmid:8285604
Grivea IN et al. Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis. 2006 Antimicrob. Agents Chemother. pmid:16377695
Dowling JN et al. Isolation and preliminary characterization of erythromycin-resistant variants of Legionella micdadei and Legionella pneumophila. 1985 Antimicrob. Agents Chemother. pmid:3985605
Edelstein PH et al. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia. 1990 Antimicrob. Agents Chemother. pmid:2073101
Waites KB et al. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. 1988 Antimicrob. Agents Chemother. pmid:2973283
Hunaiti AA and Kolattukudy PE Source of methylmalonyl-coenzyme A for erythromycin synthesis: methylmalonyl-coenzyme A mutase from Streptomyces erythreus. 1984 Antimicrob. Agents Chemother. pmid:6143534
Nielsen EI et al. Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization. 2011 Antimicrob. Agents Chemother. pmid:21807983
Villedieu A et al. Genetic basis of erythromycin resistance in oral bacteria. 2004 Antimicrob. Agents Chemother. pmid:15155239
Pankuch GA et al. MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci. 1996 Antimicrob. Agents Chemother. pmid:8878583
Wolter N et al. Telithromycin resistance in Streptococcus pneumoniae is conferred by a deletion in the leader sequence of erm(B) that increases rRNA methylation. 2008 Antimicrob. Agents Chemother. pmid:18056269
Zhu W et al. Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan. 2008 Antimicrob. Agents Chemother. pmid:18056272
Kataja J et al. Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance. 1999 Antimicrob. Agents Chemother. pmid:9869564
Morosini MI et al. In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms. 2001 Antimicrob. Agents Chemother. pmid:11502509
Giovanetti E et al. A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes. 2002 Antimicrob. Agents Chemother. pmid:12435672
Mitten MJ et al. Efficacies of ABT-773, a new ketolide, against experimental bacterial infections. 2001 Antimicrob. Agents Chemother. pmid:11502533
Reeves AR et al. Analysis of an 8.1-kb DNA fragment contiguous with the erythromycin gene cluster of Saccharopolyspora erythraea in the eryCI-flanking region. 2002 Antimicrob. Agents Chemother. pmid:12435693
Dicuonzo G et al. Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy. 2002 Antimicrob. Agents Chemother. pmid:12435707
Xu CW et al. First report of macrolide resistance gene erm(T) harbored by a novel small plasmid from Erysipelothrix rhusiopathiae. 2015 Antimicrob. Agents Chemother. pmid:25666150
Akshay S et al. Phylogenetic sequence variations in bacterial rRNA affect species-specific susceptibility to drugs targeting protein synthesis. 2011 Antimicrob. Agents Chemother. pmid:21730122
Tateda K et al. Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. 1996 Antimicrob. Agents Chemother. pmid:8891128
Hunt Gerardo S et al. Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. 1996 Antimicrob. Agents Chemother. pmid:8891154
Pannu J et al. In vitro antibacterial activity of NB-003 against Propionibacterium acnes. 2011 Antimicrob. Agents Chemother. pmid:21746943
Clermont D and Horaud T Identification of chromosomal antibiotic resistance genes in Streptococcus anginosus ("S. milleri"). 1990 Antimicrob. Agents Chemother. pmid:2285280
Fernandes PB et al. In vitro and in vivo activities of clarithromycin against Mycobacterium avium. 1989 Antimicrob. Agents Chemother. pmid:2530933
Brandt-Rauf P et al. Fluorescent assay for estimating the binding of erythromycin derivatives to ribosomes. 1978 Antimicrob. Agents Chemother. pmid:356727
Kohno Y et al. Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats. 1989 Antimicrob. Agents Chemother. pmid:2526615
Gorby GL and McGee ZA Antimicrobial interference with bacterial mechanisms of pathogenicity: effect of sub-MIC azithromycin on gonococcal piliation and attachment to human epithelial cells. 1990 Antimicrob. Agents Chemother. pmid:1982402
Wierzbowski AK et al. Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides. 2005 Antimicrob. Agents Chemother. pmid:16251306
Xie Z et al. Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates. 2005 Antimicrob. Agents Chemother. pmid:16251329
Hedberg ST et al. Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives. 2009 Antimicrob. Agents Chemother. pmid:19188396
Zhou Z et al. Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China. 2015 Antimicrob. Agents Chemother. pmid:25451048
Giovanetti E et al. Presence of the tet(O) gene in erythromycin- and tetracycline-resistant strains of Streptococcus pyogenes and linkage with either the mef(A) or the erm(A) gene. 2003 Antimicrob. Agents Chemother. pmid:12936983
Pestka S et al. Correlation of effects of erythromycin analogues on intact bacteria and on [14C]erythromycin binding to Escherichia coli ribosomes. 1974 Antimicrob. Agents Chemother. pmid:4157350
Achard A et al. Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. 2008 Antimicrob. Agents Chemother. pmid:18519724
Rouse MS et al. Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. 1997 Antimicrob. Agents Chemother. pmid:9257739
Green M et al. Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania. 2004 Antimicrob. Agents Chemother. pmid:14742197
Schwaiger K and Bauer J Detection of the erythromycin rRNA methylase gene erm(A) in Enterococcus faecalis. 2008 Antimicrob. Agents Chemother. pmid:18505854
Caldwell DB et al. Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni. 2008 Antimicrob. Agents Chemother. pmid:18779354
Fuursted K Postexposure factors influencing the duration of postantibiotic effect: significance of temperature, pH, cations, and oxygen tension. 1997 Antimicrob. Agents Chemother. pmid:9257743
Jorgensen JH et al. Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae. 2004 Antimicrob. Agents Chemother. pmid:14742216
Limburg E et al. Ribosomal alterations contribute to bacterial resistance against the dipeptide antibiotic TAN 1057. 2004 Antimicrob. Agents Chemother. pmid:14742220
Kenny GE and Cartwright FD Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin. 1991 Antimicrob. Agents Chemother. pmid:1903913
Bingen E et al. Telithromycin susceptibility and genomic diversity of macrolide-resistant serotype III group B streptococci isolated in perinatal infections. 2004 Antimicrob. Agents Chemother. pmid:14742237
Simor AE et al. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. 2007 Antimicrob. Agents Chemother. pmid:17724154
Pankuch GA et al. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents. 1998 Antimicrob. Agents Chemother. pmid:9517943
Dzyubak E and Yap MN The Expression of Antibiotic Resistance Methyltransferase Correlates with mRNA Stability Independently of Ribosome Stalling. 2016 Antimicrob. Agents Chemother. pmid:27645242
Dörries K et al. Impact of antibiotics with various target sites on the metabolome of Staphylococcus aureus. 2014 Antimicrob. Agents Chemother. pmid:25224006
Gaudreau C et al. Comparison of disk diffusion and agar dilution methods for erythromycin, ciprofloxacin, and tetracycline susceptibility testing of Campylobacter coli and for tetracycline susceptibility testing of Campylobacter jejuni subsp. jejuni. 2008 Antimicrob. Agents Chemother. pmid:18838597
Pérez-Trallero E et al. Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007). 2010 Antimicrob. Agents Chemother. pmid:20439616
Hsueh PR et al. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. 2001 Antimicrob. Agents Chemother. pmid:11600380
Nagai K et al. Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. 2001 Antimicrob. Agents Chemother. pmid:11600391
Hao H et al. Mutational and transcriptomic changes involved in the development of macrolide resistance in Campylobacter jejuni. 2013 Antimicrob. Agents Chemother. pmid:23274667
Miller AA et al. Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors. 2008 Antimicrob. Agents Chemother. pmid:18519725
Ralph ED and Amatnieks YE Potentially synergistic antimicrobial combinations with metronidazole against Bacteroides fragilis. 1980 Antimicrob. Agents Chemother. pmid:6448574
Lawrence L et al. In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens. 2008 Antimicrob. Agents Chemother. pmid:18316525
Robertson JA et al. Standardized method for determining antimicrobial susceptibility of strains of Ureaplasma urealyticum and their response to tetracycline, erythromycin, and rosaramicin. 1981 Antimicrob. Agents Chemother. pmid:7283415
Mushtaq A et al. Differential Antimicrobial Susceptibilities of Granulicatella adiacens and Abiotrophia defectiva. 2016 Antimicrob. Agents Chemother. pmid:27216060
Montilla A et al. Genetic environment of the lnu(B) gene in a Streptococcus agalactiae clinical isolate. 2014 Antimicrob. Agents Chemother. pmid:24957835
Benoni G et al. Pharmacokinetics and human tissue penetration of flurithromycin. 1988 Antimicrob. Agents Chemother. pmid:3245699
Rastogi N and Labrousse V Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex. 1991 Antimicrob. Agents Chemother. pmid:1828135
Fuchs PC et al. Selection of zone size interpretive criteria for disk diffusion susceptibility tests of three antibiotics against Streptococcus pneumoniae, using the New Guidelines of the National Committee for Clinical Laboratory Standards. 2002 Antimicrob. Agents Chemother. pmid:11796348
Ji B et al. Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice. 1991 Antimicrob. Agents Chemother. pmid:1828136
Nagai K et al. Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries. 2002 Antimicrob. Agents Chemother. pmid:11796375
Naik S and Ruck R In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex. 1989 Antimicrob. Agents Chemother. pmid:2817858
Williams MD et al. Early treatment of Campylobacter jejuni enteritis. 1989 Antimicrob. Agents Chemother. pmid:2818711
Swenson JM et al. Susceptibility of Clostridium botulinum to thirteen antimicrobial agents. 1980 Antimicrob. Agents Chemother. pmid:6998374
Waites KB et al. Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas. 2008 Antimicrob. Agents Chemother. pmid:18663020
Wu JJ et al. High incidence of erythromycin-resistant streptococci in Taiwan. 1997 Antimicrob. Agents Chemother. pmid:9087502
Allen VG et al. Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada. 2011 Antimicrob. Agents Chemother. pmid:21098249
Wang H et al. High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III. 2013 Antimicrob. Agents Chemother. pmid:23295933
Berryman DI and Rood JI Cloning and hybridization analysis of ermP, a macrolide-lincosamide-streptogramin B resistance determinant from Clostridium perfringens. 1989 Antimicrob. Agents Chemother. pmid:2552908
Hsieh YC et al. Clonal spread of highly beta-lactam-resistant Streptococcus pneumoniae isolates in Taiwan. 2008 Antimicrob. Agents Chemother. pmid:18413298
Bacheson MA et al. Antimicrobial susceptibility of intracellular Legionella pneumophila. 1981 Antimicrob. Agents Chemother. pmid:7325633
Gisby J and Bryant J Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections. 2000 Antimicrob. Agents Chemother. pmid:10639346
Brueggemann AB et al. In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. 2000 Antimicrob. Agents Chemother. pmid:10639382
Chan YY et al. Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei. 2007 Antimicrob. Agents Chemother. pmid:17145801
Gould IM et al. Interaction of imipenem with erythromycin and tetracycline assessed by microdilution checkerboard techniques. 1991 Antimicrob. Agents Chemother. pmid:1804015
Michel J et al. Effects of subminimal inhibitory concentrations of Erythromycin, Clindamycin, and Pristinamycin on the penicillinase production of Staphlyococcus aureus. 1980 Antimicrob. Agents Chemother. pmid:6965441
Brummett RE and Fox KE Vancomycin- and erythromycin-induced hearing loss in humans. 1989 Antimicrob. Agents Chemother. pmid:2669623
Veiga-Crespo P et al. Synergism between outer membrane proteins and antimicrobials. 2011 Antimicrob. Agents Chemother. pmid:21321143
Srinivasan VB et al. Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii. 2009 Antimicrob. Agents Chemother. pmid:19770280
Lehtopolku M et al. Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents. 2010 Antimicrob. Agents Chemother. pmid:20038624
Dowling JN et al. Bactericidal activity of antibiotics against Legionella micdadei (Pittsburgh pneumonia agent). 1982 Antimicrob. Agents Chemother. pmid:6927637
Hu WS et al. Outer membrane protein STM3031 (Ail/OmpX-like protein) plays a key role in the ceftriaxone resistance of Salmonella enterica serovar Typhimurium. 2009 Antimicrob. Agents Chemother. pmid:19470505
Kadlec K and Schwarz S Novel ABC transporter gene, vga(C), located on a multiresistance plasmid from a porcine methicillin-resistant Staphylococcus aureus ST398 strain. 2009 Antimicrob. Agents Chemother. pmid:19470508
Severin JA et al. Nasal carriage of methicillin-resistant and methicillin-sensitive strains of Staphylococcus sciuri in the Indonesian population. 2010 Antimicrob. Agents Chemother. pmid:20837756
Simor AE et al. Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori. 1989 Antimicrob. Agents Chemother. pmid:2712542
Jeong JW et al. In vitro and in vivo activities of LCB01-0371, a new oxazolidinone. 2010 Antimicrob. Agents Chemother. pmid:20855730
Duarte RS et al. Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources. 2005 Antimicrob. Agents Chemother. pmid:15616281
Chin NX and Neu HC In vitro activity of MC-352, a new 16-membered macrolide. 1992 Antimicrob. Agents Chemother. pmid:1416853
English AR et al. Evaluation of three 4"-deoxy-4"-sulfonamido-oleandomycin derivatives with erythromycin-like antibacterial potency. 1984 Antimicrob. Agents Chemother. pmid:6703675